drugset / Trial / NCT05275426
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out whether LY2880070 combined with the chemotherapy drug gemcitabine is an effective treatment for Ewing sarcoma or Ewing-like sarcoma.
Timeline
- Start
- 2022-03-02
- Primary completion
- 2025-08-11
- Completion
- 2025-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 100 mg/m2 | Intravenous |
| Subject | LY2880070 | Small molecule | 50 mg | Oral |